重大新药创制-话题@MedSci

#重大新药创制#

10篇内容 | 542人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2047842, encodeId=dae4204e84265, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=中国“重大新药创制”专项累计139个品种获新药证书, objectType=article, longId=176717, objectId=97131e671742, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97131e671742, replyNumber=0, likeNumber=27, createdTime=2020-02-04, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97131e671742, moduleTitle=中国“重大新药创制”专项累计139个品种获新药证书, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97131e671742)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047839, encodeId=b888204e83943, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=百济神州PARP抑制剂获十三五“国家重大新药创制专项”立项支持, objectType=article, longId=156857, objectId=480315685eeb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=480315685eeb, replyNumber=0, likeNumber=31, createdTime=2019-05-01, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=480315685eeb, moduleTitle=百济神州PARP抑制剂获十三五“国家重大新药创制专项”立项支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=480315685eeb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047838, encodeId=1ee2204e8389c, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=国家重大新药创制项目 “人用皮卡狂犬病疫苗”获临床批件, objectType=article, longId=150683, objectId=cb1f1506832b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb1f1506832b, replyNumber=0, likeNumber=33, createdTime=2019-03-20, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb1f1506832b, moduleTitle=国家重大新药创制项目 “人用皮卡狂犬病疫苗”获临床批件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb1f1506832b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047840, encodeId=79d5204e84057, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=亚盛医药多个核心品种获“十三五”国家“重大新药创制”科技重大专项支持, objectType=article, longId=157896, objectId=ae9915e896a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae9915e896a3, replyNumber=0, likeNumber=27, createdTime=2019-08-11, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae9915e896a3, moduleTitle=亚盛医药多个核心品种获“十三五”国家“重大新药创制”科技重大专项支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae9915e896a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047837, encodeId=87f9204e83747, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=聚焦“重大新药创制”，聚焦武汉, objectType=article, longId=139590, objectId=84b9139590d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84b9139590d6, replyNumber=0, likeNumber=36, createdTime=2018-12-28, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84b9139590d6, moduleTitle=聚焦“重大新药创制”，聚焦武汉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84b9139590d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047841, encodeId=a5e4204e84105, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=依生生物皮卡免疫技术平台获“十三五”重大新药创制专项立项支持, objectType=article, longId=158591, objectId=f561158591d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f561158591d1, replyNumber=0, likeNumber=45, createdTime=2019-04-23, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f561158591d1, moduleTitle=依生生物皮卡免疫技术平台获“十三五”重大新药创制专项立项支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f561158591d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047836, encodeId=0fb5204e836ac, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=【刚刚发布】科技部：关于组织重大新药创制科技重大专项2018年度课题申报的通知（附申报指南）, objectType=article, longId=107346, objectId=5c4a10e346ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c4a10e346ae, replyNumber=0, likeNumber=37, createdTime=2018-02-11, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c4a10e346ae, moduleTitle=【刚刚发布】科技部：关于组织重大新药创制科技重大专项2018年度课题申报的通知（附申报指南）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c4a10e346ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047835, encodeId=3a2c204e83556, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=桑国卫：“重大新药创制”专项的进展与“十三五”对临床试验平台的要求, objectType=article, longId=61204, objectId=6a446120454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a446120454, replyNumber=0, likeNumber=38, createdTime=2016-12-09, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a446120454, moduleTitle=桑国卫：“重大新药创制”专项的进展与“十三五”对临床试验平台的要求, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a446120454)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047834, encodeId=f7fa204e83495, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=卫计委：18个重大新药创制优先药品审评名单, objectType=article, longId=45522, objectId=46854552229, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46854552229, replyNumber=0, likeNumber=37, createdTime=2015-07-01, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46854552229, moduleTitle=卫计委：18个重大新药创制优先药品审评名单, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46854552229)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2047833, encodeId=1645204e833ab, content=<a href='/topic/show?id=c84c95e676b' target=_blank style='color:#2F92EE;'>#重大新药创制#</a>, objectTitle=中药重大新药创制显神威张伯礼院士等分获多项国家科技进步奖, objectType=article, longId=45310, objectId=e8df4531079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8df4531079, replyNumber=0, likeNumber=23, createdTime=2015-10-12, rootId=0, userName=mgqwxj, userId=669d219, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8df4531079, moduleTitle=中药重大新药创制显神威张伯礼院士等分获多项国家科技进步奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8df4531079)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

重大新药创制

2020-05-29

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

中国“重大新药创制”专项累计139个品种获新药证书

2020-02-04

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

百济神州PARP抑制剂获十三五“国家重大新药创制专项”立项支持

2019-05-01

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

国家重大新药创制项目 “人用皮卡狂犬病疫苗”获临床批件

2019-03-20

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

亚盛医药多个核心品种获“十三五”国家“重大新药创制”科技重大专项支持

2019-08-11

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

聚焦“重大新药创制”，聚焦武汉

2018-12-28

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

依生生物皮卡免疫技术平台获“十三五”重大新药创制专项立项支持

2019-04-23

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

【刚刚发布】科技部：关于组织重大新药创制科技重大专项2018年度课题申报的通知（附申报指南）

2018-02-11

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

桑国卫：“重大新药创制”专项的进展与“十三五”对临床试验平台的要求

2016-12-09

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

卫计委：18个重大新药创制优先药品审评名单

2015-07-01

mgqwxj (审核中...)

前往app查看评论内容

#重大新药创制#

中药重大新药创制显神威张伯礼院士等分获多项国家科技进步奖

2015-10-12

科室
- - 订阅+
  - 更多科室
工具
服务